FDA Pre-Submission Filed for Saliva-Based Glucose Test
A glucose salivary test, designed to replace the invasive finger prick method, has been submitted to the FDA for Pre-Submission review.
Read MorePosted by Chris Wolski | Oct 20, 2021 | Diabetes & Metabolic Diseases |
A glucose salivary test, designed to replace the invasive finger prick method, has been submitted to the FDA for Pre-Submission review.
Read MorePosted by Chris Wolski | Oct 18, 2021 | Amplification Technologies |
CRISPR technology may transform diagnostic capabilities by providing the sensitivity and flexibility of PCR tests but with increased speed and lower cost.
Read MorePosted by Chris Wolski | Sep 27, 2021 | Diabetes & Metabolic Diseases |
EKF Diagnostics is presenting its STAT-Site WB dual analyze measurement at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.
Read MorePosted by Chris Wolski | Sep 16, 2021 | Disease States |
Cairn Diagnostics has announced that the U.S. FDA has expanded the approval of the company’s 13C-Spirulina GEBT to now include “at home” administration.
Read MorePosted by Toni Mitchell | Sep 13, 2021 | Diabetes & Metabolic Diseases |
Low-cost screen printed carbon sensors — used to rapidly detect bacteria commonly found in wounds — could pave the way for a real-time medical device.
Read More